Mackenzie Financial’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.52M | Sell |
75,717
-10,392
| -12% | -$1.31M | 0.01% | 490 |
|
|
2025
Q1 | $9.52M | Buy |
86,109
+30,888
| +56% | +$3.42M | 0.01% | 469 |
|
|
2024
Q4 | $7.54M | Sell |
55,221
-31,362
| -36% | -$4.28M | 0.01% | 510 |
|
|
2024
Q3 | $9.98M | Sell |
86,583
-2,244
| -3% | -$259K | 0.01% | 442 |
|
|
2024
Q2 | $12.2M | Sell |
88,827
-2,983
| -3% | -$411K | 0.02% | 404 |
|
|
2024
Q1 | $12.7M | Sell |
91,810
-5,045
| -5% | -$696K | 0.02% | 399 |
|
|
2023
Q4 | $12.8M | Buy |
96,855
+1,224
| +1% | +$161K | 0.02% | 404 |
|
|
2023
Q3 | $10.6M | Buy |
95,631
+3,277
| +4% | +$362K | 0.02% | 421 |
|
|
2023
Q2 | $8.73M | Buy |
92,354
+44,056
| +91% | +$4.16M | 0.01% | 470 |
|
|
2023
Q1 | $4.89M | Buy |
48,298
+8,829
| +22% | +$894K | 0.01% | 557 |
|
|
2022
Q4 | $4.71M | Buy |
39,469
+4,006
| +11% | +$478K | 0.01% | 527 |
|
|
2022
Q3 | $3.77M | Sell |
35,463
-7,673
| -18% | -$815K | 0.01% | 570 |
|
|
2022
Q2 | $4.21M | Buy |
43,136
+13,240
| +44% | +$1.29M | 0.01% | 567 |
|
|
2022
Q1 | $2.8M | Buy |
29,896
+19,703
| +193% | +$1.85M | ﹤0.01% | 689 |
|
|
2021
Q4 | $868K | Sell |
10,193
-4,533
| -31% | -$386K | ﹤0.01% | 932 |
|
|
2021
Q3 | $1.41M | Buy |
14,726
+5,017
| +52% | +$481K | ﹤0.01% | 826 |
|
|
2021
Q2 | $945K | Sell |
9,709
-136
| -1% | -$13.2K | ﹤0.01% | 880 |
|
|
2021
Q1 | $957K | Sell |
9,845
-7,318
| -43% | -$711K | ﹤0.01% | 818 |
|
|
2020
Q4 | $1.65M | Buy |
17,163
+785
| +5% | +$75.2K | ﹤0.01% | 639 |
|
|
2020
Q3 | $1.58M | Buy |
16,378
+8,044
| +97% | +$774K | ﹤0.01% | 596 |
|
|
2020
Q2 | $1.02M | Buy |
8,334
+799
| +11% | +$97.5K | ﹤0.01% | 668 |
|
|
2020
Q1 | $652K | Sell |
7,535
-46
| -0.6% | -$3.98K | ﹤0.01% | 755 |
|
|
2019
Q4 | $815K | Sell |
7,581
-1,241
| -14% | -$133K | ﹤0.01% | 772 |
|
|
2019
Q3 | $795K | Buy |
8,822
+1,572
| +22% | +$142K | ﹤0.01% | 759 |
|
|
2019
Q2 | $612K | Sell |
7,250
-1,444
| -17% | -$122K | ﹤0.01% | 827 |
|
|
2019
Q1 | $766K | Buy |
8,694
+1,225
| +16% | +$108K | ﹤0.01% | 964 |
|
|
2018
Q4 | $533K | Buy |
7,469
+1,684
| +29% | +$120K | ﹤0.01% | 929 |
|
|
2018
Q3 | $711K | Buy |
5,785
+2,951
| +104% | +$363K | ﹤0.01% | 817 |
|
|
2018
Q2 | $278K | Sell |
2,834
-722
| -20% | -$70.8K | ﹤0.01% | 905 |
|
|
2018
Q1 | $295K | Buy |
+3,556
| New | +$295K | ﹤0.01% | 813 |
|